PHASE II STUDY OF GEMCITABINE AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER
Cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer (NSCLC). Many novel drugs have been used in combination with cisplatin in this setting. Of these drugs, gemcitabine is reported to have a high response rate and acceptable toxicity. The aim of this study w...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Tehran University of Medical Sciences
2006-04-01
|
| Серии: | Acta Medica Iranica |
| Предметы: | |
| Online-ссылка: | https://acta.tums.ac.ir/index.php/acta/article/view/3146 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Загрузка...